Work

Abstract 1164: SOT106, a novel best-in-class antibody-drug conjugate targeting LRRC15, to treat sarcomas and other advanced solid cancers

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-1164

Authors: Michaela Fojtu, Iva Valentová, Eliška Kohelová, Tomáš Zimmermann, Šárka Stehlíková, Irena Adkins, Nataliia Kalynovska, Lenka Palová Jelínková, Filip Jabůrek, Ann Ranger, Ulrich Moebius, Martin Steegmaier, Amy Jensen-Smith, Radek Špíšek

Institution: Sotio (Czechia)

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409689006

Cites:

Cited by:

Related to: 10